Patent · US Active

Anti oligomer antibodies and uses thereof

US9062102B2 · kind B2 · utility

0Cited by
0References
9Claims
0Family size

Assignee

Inventors

Key dates

Filing dateMar 7, 2012
Grant dateJun 23, 2015
Priority date
Expiry dateJul 30, 2032

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07K2317/76
  • WIPO fieldBiotechnology
  • WIPO sectorChemistry

Abstract

The present invention relates to antibodies and antibody fragments specific for the toxic prefibrillar aggregates of amyloid-beta peptides, and uses thereof, for example in the diagnosis and treatment of amyloid diseases such as Alzheimer's disease and related disorders. The invention further provides methods for the identification of compounds potentially useful for the treatment of an amyloid disease, such as Alzheimer's disease.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.